Current State of Sarcoma Care in Germany: Results of an Online Survey of Physicians
- 11 September 2019
- journal article
- research article
- Published by S. Karger AG in Oncology Research and Treatment
- Vol. 42 (11), 589-598
- https://doi.org/10.1159/000502758
Abstract
Background: Sarcoma treatment is a complex and multidisciplinary process. Little is known about the actual status of sarcoma care in Germany. Objectives: We evaluated: (1) on an institutional level, which physician diagnosed and treated sarcomas; (2) whether guidelines and tumor board recommendations were routinely implemented; and (c) access to which diagnosis and treatment options was regarded as problematic. We also examined factors that were associated with access problems. Methods: A cross-sectional online survey was employed among German sarcoma physicians between June 2017 and February 2018 with convenience sampling. Results: Two hundred fourteen physicians participated; 46% were oncologists and 27% surgeons, 38% worked in hospitals of maximum care, 34% were office based and 27% worked in other hospitals, 68% of all of the physicians consulted established guidelines, and 93% presented their patients in multidisciplinary tumor boards. The most common access problems were: isolated limb perfusion (39%), deep-wave hyperthermia (33%), and FDG-PET (27%), and 42% reported no access problems at all. Those physicians who treat more than 100 patients per year reported “no access problems” more frequently compared to centers with lower patient numbers (vs. 0–10 patients, OR 0.14; 95% CI 0.03–0.61; vs. 11–100 patients, OR 0.21; 95% CI 0.06–0.73). Conclusions: Access to multidisciplinary tumor boards seems to be largely guaranteed in the participants of our survey. The use of guidelines could be further implemented and expanded. The number of treated patients appears to be a significant factor to avoid access problems to treatment options.Keywords
This publication has 13 references indexed in Scilit:
- Isolated Limb Perfusion and Infusion for Extremity Soft Tissue Sarcoma: A Contemporary Systematic Review and Meta-AnalysisAnnals of Surgical Oncology, 2017
- Behandlung retroperitonealer Sarkome in DeutschlandDer Chirurg, 2017
- Nuklearmedizin in DeutschlandNuklearmedizin, 2017
- Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort)PLOS ONE, 2017
- ECCO Essential Requirements for Quality Cancer Care: Soft Tissue Sarcoma in Adults and Bone Sarcoma. A critical reviewCritical Reviews in Oncology/Hematology, 2016
- In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer ConsortiumAnnals of Oncology, 2016
- Adherence to consensus-based diagnosis and treatment guidelines in adult soft-tissue sarcoma patients: a French prospective population-based studyAnnals of Oncology, 2013
- Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhône-Alpes regionInternational Journal of Clinical Oncology, 2013
- Adherence to treatment guidelines for primary sarcomas affects patient survival: a side study of the European CONnective TIssue CAncer NETwork (CONTICANET)Annals of Oncology, 2013
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2008